Patients with metastatic melanoma who do not respond well to other therapies may be candidates for treatment with aldesleukin.
It is important to get treatment for malignant melanoma. Without treatment, the cancer will go deeper into the skin and spread throughout the body, eventually leading to death.
Malignant melanoma may develop anywhere on the body.
Though radiation therapy has a minimal role in the primary treatment of malignant melanoma, for patients who have metastatic disease, radiation may be helpful.
Some patients, such as those with IIb or stage III melanoma, are at high risk for the development of recurrence after treatment.
The predisposing causes to the development of malignant melanoma are environmental and genetic.
is malignant melanoma dominant or recessive
Malignant melanoma arises in the Stratum basale layer of the epidermal layer.
Malignant degeneration of the melanocyte gives rise to the tumor known as melanoma, which has four subtypes.
Malignant melanoma is locally staged based on the depth of penetration through the skin and its appendages.
The development of new drugs to treat melanoma depends on a better understanding of the complex processes involved in apoptosis.
skin tumour/cancer
There is also a special type of metastasis that can occur regionally with malignant melanoma; it is known as an in-transit metastasis.